REGULATED PRESS RELEASE published on 01/29/2024 at 17:55, 1 year 11 months ago Evolution du Comité exécutif de Manitou Group Manitou Group annonce une évolution au sein de son Comité exécutif avec la création de deux fonctions : un Chief Transformation & Governance Officer et un Chief Financial Officer. Hervé Rochet et Céline Brard occupent ces postes. La croissance de Manitou Group se réalise dans un monde en perpétuelle mutation, ce qui conduit à une adaptation de l'organisation du Comité exécutif Chief Financial Officer Comité Exécutif Manitou Group Évolution Chief Transformation & Governance Officer
REGULATED PRESS RELEASE published on 01/29/2024 at 17:55, 1 year 11 months ago Evolution of Manitou Group’s Executive committee Manitou Group reorganizes its Executive committee, appointing Hervé Rochet as Chief Transformation & Governance Officer and Céline Brard as Chief Financial Officer to support growth and address sustainability challenges Sustainability Executive Committee Manitou Group Hervé Rochet Céline Brard
PRESS RELEASE published on 01/29/2024 at 17:52, 1 year 11 months ago Delivery Hero to monetize its minority investment Delivery Hero SE to place up to 68,206,076 Class A shares of Deliveroo PLC through an accelerated bookbuild offering with institutional investors, representing c. 4.5% of Deliveroo's Class A share capital. The sale underlines Delivery Hero's commitment to disciplined capital allocation Delivery Hero SE Deliveroo PLC Accelerated Bookbuild Institutional Investors Capital Allocation
PRESS RELEASE published on 01/29/2024 at 17:45, 1 year 11 months ago Affluent Medical : Half-year liquidity contract statement for Affluent Medical. Affluent Medical releases half-year liquidity contract statement, showing buy and sell side executions, traded volumes, and liquidity account resources Liquidity Contract Half-year Statement Affluent Medical Buy Side Sell Side
PRESS RELEASE published on 01/29/2024 at 17:45, 1 year 11 months ago Affluent Medical : Bilan semestriel du contrat de liquidité. Bilan semestriel du contrat de liquidité pour Affluent Medical avec Kepler Cheuvreux. Décembre 2023 : 121 275 titres, 52 773,48 € en espèces. Volume échangé et transactions détaillés Contrat De Liquidité Bilan Semestriel Transactions Kepler Cheuvreux Affluent Medical
REGULATED PRESS RELEASE published on 01/29/2024 at 17:45, 1 year 11 months ago BAIKOWSKI : Indicative 2024 financial communication calendar Baikowski® (ALBKK) announces its financial communication calendar for 2024, including the release dates for 2023 earnings and annual report, and 2024 half-year revenue and earnings Baikowski ALBKK Financial Communication Calendar 2023 Earnings 2024 Half-year Revenue
REGULATED PRESS RELEASE published on 01/29/2024 at 17:45, 1 year 11 months ago BAIKOWSKI : Calendrier indicatif de communication financière 2024 Baikowski® (ALBKK - ISIN : FR0013384369) annonce son calendrier de communication financière pour 2024, y compris les dates de publication des chiffres d'affaires et des résultats semestriels et annuels Chiffre D'affaires Communication Financière Résultats Annuels Baikowski® Calendrier 2024
REGULATED PRESS RELEASE published on 01/29/2024 at 17:45, 1 year 11 months ago Chiffres d’affaires et trafic d’APRR pour l’année 2023 et le 4e trimestre 2023 APRR publie ses chiffres d'affaires et de trafic pour l'année 2023 et le 4e trimestre 2023, avec une augmentation de 5,7% du chiffre d'affaires hors construction et de 2,5% du trafic total Chiffre D'affaires Trafic Hausse APRR 4e Trimestre 2023
REGULATED PRESS RELEASE published on 01/29/2024 at 17:45, 1 year 11 months ago APRR's revenue and traffic figures for 2023 and Q4 2023 APRR reports consolidated revenue of €3,018.7 million and 2.8% traffic growth in 2023. Aliaé (A79) contributes €44.7 million in revenue, opened on Nov. 4, 2022 Revenue APRR Traffic Growth Aliaé A79
PRESS RELEASE published on 01/29/2024 at 17:40, 1 year 11 months ago Valbiotis publie son calendrier financier de l’exercice 2024 Valbiotis publie son calendrier financier pour l'exercice 2024 avec les dates de publication du rapport annuel 2023, de l'assemblée générale annuelle et du rapport semestriel 2024 Calendrier Financier Valbiotis Exercice 2024 Compléments Alimentaires Innovation Scientifique
Published on 01/16/2026 at 02:50, 1 hour 32 minutes ago Early Warning Press Release - Titanium Enters into Agreement to be Taken Private
Published on 01/16/2026 at 00:00, 4 hours 22 minutes ago LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based Obesity Therapies
Published on 01/15/2026 at 23:20, 5 hours 2 minutes ago Guanajuato Silver Closes Acquisition of Bolanitos Gold-Silver Mine
Published on 01/15/2026 at 23:15, 5 hours 7 minutes ago Drilling Resumes on The Nighthawk Gold/Silver Project, Nevada
Published on 01/15/2026 at 22:02, 6 hours 20 minutes ago Unusual Machines Announces $2.1 Million Order for Drone Components
Published on 01/16/2026 at 04:05, 17 minutes ago Chow Tai Fook Jewellery Launches Next Phase of International Expansion with New Bangkok Opening and Appointment of Global Brand Ambassador
Published on 01/16/2026 at 00:30, 3 hours 51 minutes ago German Engraving Businesses Focus on Customization and Advanced Laser Technology in the New Year
Published on 01/15/2026 at 23:23, 4 hours 59 minutes ago Klöckner & Co and Worthington Steel sign business combination agreement
Published on 01/15/2026 at 23:22, 4 hours 59 minutes ago EQS-Adhoc: Klöckner & Co SE signs business combination agreement with Worthington Steel and supports voluntary public takeover offer to all shareholders
Published on 01/15/2026 at 19:43, 8 hours 38 minutes ago InVivo Group and the Founders jointly announce, as part of a review of their strategic priorities, their intention to file a public buy-out offer, followed by a squeeze-out of TERACT shares
Published on 01/15/2026 at 18:06, 10 hours 15 minutes ago SMTPC - Communiqué sur le Chiffre d'affaires du 4ème trimestre 2025
Published on 01/15/2026 at 17:57, 10 hours 24 minutes ago InVivo Group et les Fondateurs annoncent de concert, dans le cadre de l’évolution de leurs orientations stratégiques, leur intention de déposer une offre publique de retrait suivie d’un retrait obligatoire sur les titres TERACT